检索结果-南通市图书馆

electrocardiographic Safety of Daily Hydroxychloroquine 400 mg Plus Azithromycin 250 mg as an Ambulatory Treatment for COVID-19 Patients in Cameroon

引用

World Journal of Cardiovascular Diseases 2021年第2期11卷 106-112页

作者： Liliane Mfeukeu-Kuate William Djomo Ngatchou Mazou Ngou Temgoua Charles Kouanfack Daniel Lemoungoum Joel Noutakdie Tochie Armel Zemsi Lauriane Fomete Skinner Lekelem Sylvain Zemsi Joelle Sobngwi Thierry Ntandzi Christian Ngongang Ouankou Yves Wasnyo Antoinette Tsama Assiga Jan René Nkeck Ahmadou Musa Jingi Magellan Guewo Eric Walter Pefura Yone Charlotte Moussi Omgba Paul Owono Etoundi Jean Cyr Yombi Samuel Kingue Alain Menanga Jacqueline Ze Minkande Pierre Ongolo Zogo Jean Claude Mbanya Pierre Joseph Fouda Eugène Sobngwi Central Hospital of Yaoundé Yaoundé Cameroon Department of Internal Medicine and specialities Faculty of Médicine and Biomedical Sciences of the University of Yaounde I Yaoundé Cameroon Department of Surgery University of Douala Hypertension Clinic and Cardiac Surgery Department St Pierre Hospital Université libre de Bruxelles Brussels Belgium Faculty of Medicine and Pharmaceutical Sciences of Dschang University Dschang Cameroon Hypertension Clinic and Cardiology Department Erasme Hospital University of Brussels Brussels Belgium Research-Health and Development Yaoundé Cameroon and London School of Economics and Political Sciences London UK ANRS Cameroon Yaoundé Camerroon Faculty of Health Sciences University of Bamenda Bamenda Cameroon Jamot Hospital of Yaounde Yaounde Cameroon Regional Public Health Delegation for the Centre Ministry of Public Health Cameroon Yaoundé Cameroon Department of Surgery and Specialities Faculty of Medicine and Biomedical Sciences University of Yaounde I Yaounde Cameroon Centre for the Development of Good Health Practices Yaoundé Cameroon

Objective: To determine the early electrocardiographic changes in a cohort of ambulatory cameroonian COVID-19 patients treated with hydroxychlo- roquine and Azithromycin. Design: Prospective study. Setting: Treatment centres of the city of Yaounde, Cameroon, from May 7th to 24th 2020. Participants: We enrolled 51 consecutive confirmed COVID-19 on RT-PCR who having mild forms of COVID-19 and treated by hydroxychloroquine 200 mg twice daily during seven #days plus Azithromycin 500 mg the first day and 250 mg the remaining 4 days as per national standard. Main Outcomes Measures: The primary end-point was the change in QTc interval between day 0 (D0), day 3 (D3) and day 7 (D7). Secondary endpoints were changes in all other cardiac electrical conductivity patterns and the occurrence of clinical arrhythmic events during the course of treatment. Results: The population (29 men and 22 women) was aged 39 ± 11 years (range 17 to 61 years

关键词： early electrocardiographic changes COVID-19 Hydroxychloroquine Azithromycin Cameroon

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：